“Limiting viral shedding… would reduce transmission to family members and others, which is crucial to controlling epidemic disease spread.” – Stanford University researchers
Scientists at Stanford Medicine are investigating whether a molecule called interferon-lambda can help people with mild cases of COVID-19 feel better and reduce their transmission of the disease-causing virus.
A clinical trial is underway at Stanford Medicine to determine whether a drug can keep people who’ve just tested positive for the coronavirus out of the hospital, help them recover faster and make them safer to be around in the meantime.
The researchers also want to know whether the drug stems viral shedding, which would reduce transmission to family members and the community.The drug being looked at, interferon-lambda, is a manufactured form of a naturally occurring protein that’s been given in previous clinical trials to more than 3,000 people infected with hepatitis viruses.
